The role of HER2/neu expression and trastuzumab in non-small cell lung cancer
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 31, 75-82
- https://doi.org/10.1053/j.seminoncol.2003.12.018
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Assessment of Methods for Tissue-Based Detection of the HER-2/neu Alteration in Human Breast Cancer: A Direct Comparison of Fluorescence In Situ Hybridization and ImmunohistochemistryJournal of Clinical Oncology, 2000
- Testing for erbB-2 by Immunohistochemistry in Breast CancerAmerican Journal of Clinical Pathology, 2000
- HER-2/neu Protein Expression in Breast Cancer Evaluated by ImmunohistochemistryAmerican Journal of Clinical Pathology, 2000
- Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry for the Evaluation of HER-2/neu in Breast CancerJournal of Clinical Oncology, 1999
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Amplification of c- erb B-2 and Aggressive Human Breast Tumors?Science, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.Molecular and Cellular Biology, 1986
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985